Suchergebnisse - (Person:"De Meyer, Sandra")

PubPharm (102)

51

Patterns of viral load decline with telaprevir-based therapy in patients with genotype 1 chronic HCV infection

enthalten in: Journal of clinical virology | 2014

von Picchio, G. | De Meyer, S. | Dierynck, I. | +10

52

Telaprevir Twice Daily Is Noninferior to Telaprevir Every 8 Hours for Patients With Chronic Hepatitis C

enthalten in: Gastroenterology | 2014

von Buti, M. | Agarwal, K. | Horsmans, Y. | +13

53

Deep-Sequencing Analysis of the Gene Encoding the Hepatitis C Virus Nonstructural 3-4A Protease Confirms a Low Prevalence of Telaprevir-Resistant Variants at Baseline and the End of the REALIZE Study

Erschienen: 2014

von Dierynck, I. | Thys, K. | Ghys, A. | +5

54

Telaprevir activity in treatment-naive patients infected hepatitis C virus genotype 4 : a randomized trial

enthalten in: The Journal of infectious diseases | 2013

von Benhamou, Y. | Moussalli, J. | Ratziu, V. | +7

CommentIn: J Infect Dis. 2014 Dec 1;210(11):1855-6. - PMID 24970848

55

Evolution of treatment-emergent resistant variants in telaprevir phase 3 clinical trials

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2013

von Sullivan, J. | De Meyer, S. | Bartels, D. | +14

56

Limited impact of IL28B genotype on response rates in telaprevir-treated patients with prior treatment failure

enthalten in: Journal of hepatology | 2013

von Pol, S. | Aerssens, J. | Zeuzem, S. | +14

CommentIn: J Hepatol. 2013 May;58(5):847-9. - PMID 23416431

57

Limited impact of IL28B genotype on response rates in telaprevir-treated patients with prior treatment failure

enthalten in: Journal of hepatology | 2013

von Pol, S. | Aerssens, J. | Zeuzem, S. | +14

58

Sustained virologic response rates with telaprevir by response after 4 weeks of lead-in therapy in patients with prior treatment failure

enthalten in: Journal of hepatology | 2013

von Foster, G. | Zeuzem, S. | Andreone, P. | +12

CommentIn: J Hepatol. 2013 Jun;58(6):1259. - PMID 23376359

59

Sustained virologic response rates with telaprevir by response after 4weeks of lead-in therapy in patients with prior treatment failure

enthalten in: Journal of hepatology | 2013

von Foster, G. | Zeuzem, S. | Andreone, P. | +12

60

Hepatitis C virus variants with decreased sensitivity to direct-acting antivirals (DAAs) were rarely observed in DAA-naive patients prior to treatment

enthalten in: Journal of virology | 2013

von Bartels, D. | Sullivan, J. | Zhang, E. | +8